FDA Approves Trastuzumab-strf for HER2-Overexpressing Breast

The FDA has approved trastuzumab-strf for HER2-overexpressing breast cancer and HER2-overexpressing metastatic gastric or GEJ adenocarcinoma.

Related Keywords

China , Ukraine , United States , Philippines , Poland , America , Chrys Kokino , Henlius Trastuzumab , Binish Chudgar , Jason Zhu , European Medicines Agency , National Medical Products Administration , Henlius Biotech Inc , Intas Pharmaceuticals , European Union , European Commission , Henlius Biotech , North America , Accord Biopharma , Trastuzumab Strf , Biosimilar , Her2 Overexpressing Breast Cancer , Her2 Overexpressing Metastatic Gastric Or Gej Adenocarcinoma , Btrastuzumab , Herceptin , Hercessi ,